Vividion Therapeutics
Vividion’s chemoproteomics platform turns new chemistry into maps of the druggable proteome. With Vividion scientists the lab has built enantiocontrolled azetidine libraries and complete sets of saturated-heterocycle stereoprobes for chemoproteomic discovery.
San Diego, California · A Bayer company since 2021
- Papers together
- 2
- Years
- 2025–present
- Co-authors
- 18
Chemistry we made together
All 2 papers with Vividion Therapeutics
-
Radical Cross-Coupling Delivers Complete Sets of Saturated-Heterocyclic Regio- and Stereoprobes for Chemoproteomic Discovery
- Vividion Therapeutics Ann Shih, Annabel Q. Ansel, Benjamin D. Horning, Brian E. Nordin, Brian N. Cook, Christie L. Eissler, Christopher A. Toth, Cian Kingston, Cody L. Fullenwider, Connor Scheuerman, David S. Weinstein, Gabriel M. Simon, Jonathan Pollock, Matthew P. Patricelli, Steffen M. Bernard, Steven C Wang, Tracey Nguyen
-
Enantiocontrolled Azetidine Library Synthesis via Strain-Release Functionalization of 1-Azabicyclobutanes
- Vividion Therapeutics Benjamin F. Cravatt
No papers match these filters.
Our co-authors at Vividion Therapeutics
Annabel Q. Ansel · Steffen M. Bernard · Brian N. Cook · Benjamin F. Cravatt · Christie L. Eissler · Cody L. Fullenwider · Benjamin D. Horning · Cian Kingston · Tracey Nguyen · Brian E. Nordin · Matthew P. Patricelli · Jonathan Pollock · Connor Scheuerman · Ann Shih · Gabriel M. Simon · Christopher A. Toth · Steven C Wang · David S. Weinstein
More partners
Enamine
HitGen Hongene Biotech Hongene Biotech IKA IKA InduPro Therapeutics InduPro Therapeutics
KULR Technology RQx Pharmaceuticals RQx Pharmaceuticals Socrates Biosciences Socrates Biosciences The Medicines Company The Medicines Company Interested in collaborating with the Baran lab?
If your team has a problem that matters, a molecule no one can make, a reaction that will not scale, a reagent that should exist, we would love to hear about it.
Email Philor write to pbaran@scripps.edu

